Granules India Secures First to File Status for CNS Depressant Generic, Boosting Growth Prospects
Granules India Limited, a prominent player in the pharmaceutical sector, has achieved a significant milestone by securing the coveted First to File (FTF) status from the United States Food and Drug Administration (USFDA) for its generic version [...]
